Literature DB >> 35110238

Adult Primary Antibody Deficiencies and the Lung.

Ebru Damadoğlu1.   

Abstract

Primary antibody deficiency diseases result from a genetic defect that causes misfunction of 1 or more of the immune system elements. Due to the increased awareness among physicians and the success of new treatment modalities, the number of pediatric patients reaching adult age and the number of patients diagnosed in adult age is increasing. Adult patients comprise more than half of the total cases. Primary antibody deficiencies are the most common immunodeficiency type in adults, and these may cause recurrent upper and lower respiratory tract infections and result in the development of bronchiectasis. Among non-infectious pulmonary complications, any type of interstitial lung disease may be seen; however, a special type seen in patients with common variable immunodeficiency, namely granulomatous lymphocytic interstitial lung disease, is the one most commonly investigated. Underlying or accompanying immunodeficiency may be present in patients with asthma and chronic obstructive pulmonary disease, especially if the disease requires frequent hospitalizations and/or is severe. Early diagnosis and appropriate management of primary antibody deficiency diseases in patients with respiratory symptoms are crucial to decrease complications and increase survival.

Entities:  

Year:  2021        PMID: 35110238      PMCID: PMC8975364          DOI: 10.5152/TurkThoracJ.2021.20097

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  34 in total

1.  Serum IgG and risk of exacerbations and hospitalizations in chronic obstructive pulmonary disease.

Authors:  Fernando Sergio Leitao Filho; Seung Won Ra; Andre Mattman; Robert S Schellenberg; Nick Fishbane; Gerard J Criner; Prescott G Woodruff; Stephen C Lazarus; Richard Albert; John E Connett; Meilan K Han; Fernando J Martinez; Janice M Leung; S F Paul Man; Shawn D Aaron; Robert M Reed; Don D Sin
Journal:  J Allergy Clin Immunol       Date:  2017-04-27       Impact factor: 10.793

Review 2.  Lung disease in primary antibody deficiency.

Authors:  Nisha Verma; Bodo Grimbacher; John R Hurst
Journal:  Lancet Respir Med       Date:  2015-07-15       Impact factor: 30.700

3.  Selective IgA deficiency: clinical and laboratory features of 118 children in Turkey.

Authors:  Caner Aytekin; Nilden Tuygun; Selim Gokce; Figen Dogu; Aydan Ikinciogullari
Journal:  J Clin Immunol       Date:  2012-05-01       Impact factor: 8.317

4.  The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency.

Authors:  J E S Park; I Beal; J P Dilworth; V Tormey; J Haddock
Journal:  Eur J Radiol       Date:  2005-06       Impact factor: 3.528

5.  Phenotyping Adults with Non-Cystic Fibrosis Bronchiectasis: A 10-Year Cohort Study in a French Regional University Hospital Center.

Authors:  Matthieu Buscot; Héloïse Pottier; Charles-Hugo Marquette; Sylvie Leroy
Journal:  Respiration       Date:  2016-06-24       Impact factor: 3.580

6.  Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD.

Authors:  Fernando Sergio Leitao Filho; Seung Won Ra; Andre Mattman; Robert S Schellenberg; Gerard J Criner; Prescott G Woodruff; Stephen C Lazarus; Richard Albert; John E Connett; Meilan K Han; Fernando J Martinez; Janice M Leung; S F Paul Man; Shawn D Aaron; Robert M Reed; Don D Sin
Journal:  Respir Res       Date:  2018-02-14

7.  Duration of frequent or severe respiratory tract infection in adults before diagnosis of IgG subclass deficiency.

Authors:  James Barton; Clayborn Barton; Luigi Bertoli
Journal:  PLoS One       Date:  2019-05-21       Impact factor: 3.240

8.  Secretory IgA: Designed for Anti-Microbial Defense.

Authors:  Per Brandtzaeg
Journal:  Front Immunol       Date:  2013-08-06       Impact factor: 7.561

Review 9.  The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation.

Authors:  Ulrich Baumann; John M Routes; Pere Soler-Palacín; Stephen Jolles
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

Review 10.  Respiratory microbiome and epithelial interactions shape immunity in the lungs.

Authors:  Rachele Invernizzi; Clare M Lloyd; Philip L Molyneaux
Journal:  Immunology       Date:  2020-04-14       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.